Search by Drug Name or NDC
NDC 61314-0245-02 Betaxolol Hydrochloride 5.6 mg/mL Details
Betaxolol Hydrochloride 5.6 mg/mL
Betaxolol Hydrochloride is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sandoz Inc. The primary component is BETAXOLOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Ophthalmic betaxolol is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Betaxolol is in a class of medications called beta blockers. It works by decreasing the pressure in the eye.
Related Packages: 61314-0245-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Betaxolol Ophthalmic
Product Information
NDC | 61314-0245 |
---|---|
Product ID | 61314-245_c30e555b-1a79-4c3e-b79d-8c1d950fd832 |
Associated GPIs | 86250010102005 |
GCN Sequence Number | 007857 |
GCN Sequence Number Description | betaxolol HCl DROPS 0.5 % OPHTHALMIC |
HIC3 | Q6G |
HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
GCN | 33210 |
HICL Sequence Number | 005168 |
HICL Sequence Number Description | BETAXOLOL HCL |
Brand/Generic | Generic |
Proprietary Name | Betaxolol Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Betaxolol Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 5.6 |
Active Ingredient Units | mg/mL |
Substance Name | BETAXOLOL HYDROCHLORIDE |
Labeler Name | Sandoz Inc |
Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA AUTHORIZED GENERIC |
Application Number | NDA019270 |
Listing Certified Through | 2024-12-31 |
Package
NDC 61314-0245-02 (61314024502)
NDC Package Code | 61314-245-02 |
---|---|
Billing NDC | 61314024502 |
Package | 1 BOTTLE, PLASTIC in 1 CARTON (61314-245-02) / 15 mL in 1 BOTTLE, PLASTIC |
Marketing Start Date | 2000-05-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |